Aligos Therapeutics, Inc. utilized LinkedIn for sharing company updates.
4 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aligos Therapeutics, Inc. utilized LinkedIn for sharing company updates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Aligos Therapeutics, Inc.
Nothing else this week.
-
LinkedIn
American social networking website for people in professional occupations
Related events
- Pelthos Therapeutics Inc. followed another company on LinkedIn on November 1, 2026.
- Syndax Pharmaceuticals has FDA-approved therapies in its pipeline and uses LinkedIn for company communication.
- A company with FDA-approved therapies used LinkedIn for information and its board approved a stock award for CFO hiring.
- Kura Oncology announced the commercialization of an FDA-approved drug and began using LinkedIn for company information.
- University of Liberia is utilizing LinkedIn to provide updates regarding its campaigns.
Coverage
Newest first; wire copies grouped- GlobeNewswireAligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS)
- GlobeNewswireAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”,
- GlobeNewswireAligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025 SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinica